Literature DB >> 16355505

Melioidosis in tsunami survivors.

Eugene Athan, Anthony M Allworth, Catherine Engler, Ivan Bastian, Allen C Cheng.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16355505      PMCID: PMC3366758          DOI: 10.3201/eid1110.050740

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: A tsunami devastated coastal areas of the Indian Ocean rim in December 2004. Of the affected countries, more than half of the ≈300,000 deaths occurred in the Aceh Province of Indonesia, close to the epicenter of the earthquake near northern Sumatra. Infrastructure, including medical and laboratory facilities, in this region was severely damaged. Of >1,000,000 survivors, >500,000 likely were injured. Most injuries were from trauma, but a substantial number were caused by aspiration of, or immersion in, saltwater that may have been contaminated by soil, sewage, or other environmental sources. Melioidosis, caused by the saprophytic gram-negative bacillus Burkholderia pseudomallei, is endemic in Southeast Asia and northern Australia. Most cases have been found in northeastern Thailand, Singapore, and northern Australia. Melioidosis has been reported only sporadically from Indonesia and mainly in returning travelers (–). In the context of acute medical relief efforts to the town of Banda Aceh, we report on 10 patients with pneumonia, including 4 patients with culture-confirmed melioidosis, after their immersion in contaminated saltwater during the tsunami. Clinical and laboratory services were reestablished on January 3, 2005, at Fakinah Hospital and on January 13, 2005, at Zainoel Abidin Hospital by the relief teams. Patients were identified opportunistically; details of treatment and outcome were reviewed retrospectively. Cultures were taken when clinically indicated and when specimens were available. Sputum cultures were plated onto horse blood agar, cystine lactose electrolyte-deficient agar, Haemophilus agar, and colistin/nalidixic acid blood agar incubated in a candle jar at 35°C for <3 days. Colonies suspicious for B. pseudomallei were subcultured to B. cepacia–selective media (Oxoid, Adelaide, South Australia, Australia). Blood cultures and screening cultures of throat and rectum specimens were not performed routinely. Isolates of B. pseudomallei and characteristic antimicrobial drug susceptibilities were confirmed with API20NE (bioMérieux, Marcy l'Etoile, France). From January 3 to January 28, 2005, a total of 10 cases of postimmersion pneumonia were identified. All patients were <18 years of age and previously well; 6 were male. No cases were epidemiologically linked to others. The patients were treated 10–35 days after the tsunami. Eight had bilateral alveolar opacities on chest radiograph; 3 also had empyema. Clinical, radiologic, and microbiologic details are summarized in the Table.
Table

Clinical details of pneumonia patients after tsunami in Banda Aceh, Indonesia, January 2003*

Patient no.Age (y)/sexRadiograph resultsComplicationsMicrobiologic test resultsDays before treatmentAntimicrobial drugAcute outcome
17/MBilateral infiltratesCavitationNo cultures taken19MeropenemFever resolved, improving @30 days
212/MBilateral infiltratesPseudomonas aeruginosa (sputum)37MeropenemSerious but stable @12 days
35/MUnilateral infiltratesCavitationNo cultures taken10MeropenemFever resolved, improving @39 days
415/FBilateral infiltratesPneumothorax, empyemaBurkholderia pseudomallei (sputum)27Meropenem 2 wks, then oral TMP-SMX and coamoxiclavFully recovered, discharged @20 days
514/MBilateral infiltratesP. aeruginosa (sputum)35MeropenemImproving @11 days
66/MBilateral infiltratesP. aeruginosa (sputum)30MeropenemImproving @19 days
718 mo/MBilateral infiltratesEmpyemaB. pseudomallei (pleural fluid)30MeropenemImproving @23 days
810/FBilateral infiltratesEmpyemaP. aeruginosaB. pseudomalleiKlebsiella sp. (pleural fluid)30MeropenemImproving @23 days
913/FBilateral infiltratesP. aeruginosaB. pseudomallei (sputum)33MeropenemImproving @18 days
1017/FUnknownUnknownNocardia spp. (sputum)21Ticarcillin/clavulanate, ciprofloxacinNot improving, outcome unknown @12 days

*ICU, intensive care unit; TMP-SMX, trimethoprim-sulfamethoxazole.

*ICU, intensive care unit; TMP-SMX, trimethoprim-sulfamethoxazole. The sputum cultures of 4 patients were positive for B. pseudomallei. Except posttsunami exposure, none had risk factors for melioidosis, including diabetes, renal failure, or thalassemia. Other co-isolated organisms included Pseudomonas aeruginosa and Klebsiella sp.; 2 patients who did not have cultures taken had cavitatory lung disease. All patients with melioidosis were treated with meropenem, and all but 1 clinically improved in the hospital. This is the second report of melioidosis from within Indonesia () and the second published report of melioidosis after the tsunami disaster (). Cases from this event were included in a preliminary communication (). However, exported cases of melioidosis from Indonesia, as well as the neighboring countries of Singapore and Malaysia, have been reported previously (,), a likely indication that this infection is underrecognized in Indonesia. Melioidosis has also been reported in tsunami survivors from Sri Lanka () and Thailand. A striking feature of this event is the lack of predisposing factors and the young age of the patients. This feature likely represents the unique mode of acquisition and magnitude of the infecting inoculum, as well as the vulnerability of children to near drowning after flooding. One third of the patients had empyema, which reflects both the severity of pulmonary disease and delay in receiving medical care. Undoubtedly, a substantial selection bias occurred by including only patients who sought hospital treatment, and this is suggested by the low death rate. Melioidosis, acquired after near drowning, has been associated with a short incubation period and severe disease. However, patients who had melioidosis before medical aid arrived in the region would likely have died. Patients with longer incubation periods also may have acquired melioidosis through contaminated wounds with subsequent hematogenous dissemination. Medical services to the region were by no means comprehensive during this time. Many other patients with postimmersion pneumonia and melioidosis may have been overlooked, both during the study (for persons who were not treated or if cultures were not taken) and afterwards; the incubation period of melioidosis may be <62 years. A further limitation is the lack of denominator data because no reliable records were kept on hospital admissions, and the exact number of survivors is not yet known. Conflicting data are found on the accuracy of the API20NE test kit used to identify bacteria in this study (–), but we believe that the clinical features and microbiologic findings suggest melioidosis. This report confirms that B. pseudomallei exists in the Aceh Province of Indonesia and that melioidosis and gram-negative pneumonia may complicate saltwater immersion in this region. After near drowning incidents, melioidosis is characterized by severe pulmonary disease, including pleural effusions. Clinicians worldwide should be mindful that melioidosis in tsunami survivors may appear many years after exposure.
  8 in total

1.  Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei.

Authors:  Peter Lowe; Catherine Engler; Robert Norton
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

2.  Preliminary evaluation of the API 20NE and RapID NF plus systems for rapid identification of Burkholderia pseudomallei and B. mallei.

Authors:  Mindy B Glass; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Tsunami lung: a necrotising pneumonia in survivors of the Asian tsunami.

Authors:  Anthony M Allworth
Journal:  Med J Aust       Date:  2005-04-04       Impact factor: 7.738

4.  Burkholderia pseudomallei infections in Finnish tourists injured by the December 2004 tsunami in Thailand.

Authors:  Tea Nieminen; Martti Vaara
Journal:  Euro Surveill       Date:  2005-03-03

5.  Imported melioidosis in England and Wales.

Authors:  D A Dance; M D Smith; H M Aucken; T L Pitt
Journal:  Lancet       Date:  1999-01-16       Impact factor: 79.321

6.  Identification of Pseudomonas pseudomallei in clinical practice: use of simple screening tests and API 20NE.

Authors:  D A Dance; V Wuthiekanun; P Naigowit; N J White
Journal:  J Clin Pathol       Date:  1989-06       Impact factor: 3.411

7.  Potential misidentification of Burkholderia pseudomallei by API 20NE.

Authors:  T J Inglis; D Chiang; G S Lee; L Chor-Kiang
Journal:  Pathology       Date:  1998-02       Impact factor: 5.306

8.  Melioidosis presenting as an infected intrathoracic subclavian artery pseudoaneurysm treated with femoral vein interposition graft.

Authors:  Nancy Schindler; Keith D Calligaro; Matthew J Dougherty; James Diehl; Ketang H Modi; Michael N Braffman
Journal:  J Vasc Surg       Date:  2002-03       Impact factor: 4.268

  8 in total
  12 in total

1.  CD4+ T-cell immunity to the Burkholderia pseudomallei ABC transporter LolC in melioidosis.

Authors:  Karen K Chu; Patcharaporn Tippayawat; Nicola J Walker; Sarah V Harding; Helen S Atkins; Bernard Maillere; Gregory J Bancroft; Ganjana Lertmemongkolchai; Daniel M Altmann
Journal:  Eur J Immunol       Date:  2010-12-03       Impact factor: 5.532

2.  A Burkholderia pseudomallei deltapurM mutant is avirulent in immunocompetent and immunodeficient animals: candidate strain for exclusion from select-agent lists.

Authors:  Katie L Propst; Takehiko Mima; Kyoung-Hee Choi; Steven W Dow; Herbert P Schweizer
Journal:  Infect Immun       Date:  2010-04-19       Impact factor: 3.441

Review 3.  Infectious Diseases After Hydrologic Disasters.

Authors:  Stephen Y Liang; Nicole Messenger
Journal:  Emerg Med Clin North Am       Date:  2018-09-06       Impact factor: 2.264

4.  The occurrence of melioidosis is related to different climatic conditions in distinct topographical areas of Taiwan.

Authors:  J-J Mu; P-Y Cheng; Y-S Chen; P-S Chen; Y-L Chen
Journal:  Epidemiol Infect       Date:  2013-05-29       Impact factor: 4.434

5.  Type 3 secretion system cluster 3 is a critical virulence determinant for lung-specific melioidosis.

Authors:  Maria G Gutierrez; Tia L Pfeffer; Jonathan M Warawa
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

6.  Molecular basis of rare aminoglycoside susceptibility and pathogenesis of Burkholderia pseudomallei clinical isolates from Thailand.

Authors:  Lily A Trunck; Katie L Propst; Vanaporn Wuthiekanun; Apichai Tuanyok; Stephen M Beckstrom-Sternberg; James S Beckstrom-Sternberg; Sharon J Peacock; Paul Keim; Steven W Dow; Herbert P Schweizer
Journal:  PLoS Negl Trop Dis       Date:  2009-09-22

7.  Osteomyelitis of parietal bone in melioidosis.

Authors:  Nina G Miksić; Nadja Alikadić; Tatjana Z Lejko; Alenka Andlovic; Jernej Knific; Janez Tomazic
Journal:  Emerg Infect Dis       Date:  2007-08       Impact factor: 6.883

Review 8.  Respiratory Infections Following Earthquake-Induced Tsunamis: Transmission Risk Factors and Lessons Learned for Disaster Risk Management.

Authors:  Maria Mavrouli; Spyridon Mavroulis; Efthymios Lekkas; Athanassios Tsakris
Journal:  Int J Environ Res Public Health       Date:  2021-05-06       Impact factor: 3.390

9.  Impact of the Tohoku earthquake and tsunami on pneumonia hospitalisations and mortality among adults in northern Miyagi, Japan: a multicentre observational study.

Authors:  Hisayoshi Daito; Motoi Suzuki; Jun Shiihara; Paul E Kilgore; Hitoshi Ohtomo; Konosuke Morimoto; Masayuki Ishida; Taro Kamigaki; Hitoshi Oshitani; Masahiro Hashizume; Wataru Endo; Koichi Hagiwara; Koya Ariyoshi; Shoji Okinaga
Journal:  Thorax       Date:  2013-02-19       Impact factor: 9.139

10.  Identification of melioidosis outbreak by multilocus variable number tandem repeat analysis.

Authors:  Bart J Currie; Asha Haslem; Talima Pearson; Heidie Hornstra; Benjamin Leadem; Mark Mayo; Daniel Gal; Linda Ward; Daniel Godoy; Brian G Spratt; Paul Keim
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.